Nevertheless, plasma Reg3a levels was found to be higher in patients with GIS GVHD than those with other GVHD, but this difference did not reach statistical significance (11850 ng/dL vs. 6180 ng/dL, P = 0.132). This evidence concerns the gene REG3A and graft versus host disease.